This is the 2nd episode, of the 'Microbiome Gazers'. Proudly presented by BugSpeaks® and Leucine Rich Bio.
In this interactive session, under the aegis of BugSpeaks live stream series, co-founders of Leucine Rich Bio and developers of South Asia's first gut microbiome test - BugSpeaks® - Dr Debojyoti Dhar and Mr Kumar Sankaran talk about the evolution of microbiome reporting with respect to BugSpeaks®. The speakers discuss about the various facets of BugSpeaks® report. The key highlight was the "question-answer" session between the attendees and the panellists.
Observations about microbiome reporting in general and how the BugSpeaks® report have evolved in the last 2-3 years.
How the transition from "one-page clinical report" to "an elaborate report" happened, both with BugSpeaks® and other microbiome companies across the world.
How the intriguing nature of microbiome, which has been interesting even to the lay person, have driven a detailed BugSpeaks® report over the years.
How balancing the aspects of microbiome that is relevant to both clinical doctor and common man was key to this reporting.
What kind of diseases would BugSpeaks® analysis, reporting and recommendations would be most impactful?
The causation vs correlation/association debate and how our disease risk estimation has been conceptualized.
Other salient features of BugSpeaks® report, including the Gut Microbiome Index [GMI], pathogen characterization, and most importantly the personalized 3-Phase dietary recommendations.
How BugSpeaks® GMI is different from that of Bacteroidetes to Firmicutes ratio or any other metric generally used and how we are on a quest for a universal standard for representing the extent of dysbiosis of gut microbiome.
More on the direction of personalized nutrition and diet and how BugSpeaks® can contribute to this area.
Why a "single time, eat or don’t eat kind of diet" has been unsuccessful and why multiphase dietary recommendations is the way to go forward.
Detailed description of the 3-Phase Diet and importance of Supplements during Phase 2 and why going natural is important than finding off the shelf probiotics.
Why achieving personalized nutrition is extremely hard.
How all of these would aid everyone from individuals to nutritionists to clinicians to take actionable efforts towards better health.
They wrap up the discussion by answering questions from the attendees.